MBP metabolic pharmaceuticals limited

undervalued and starting to attract attention, page-8

  1. 5,363 Posts.
    lightbulb Created with Sketch. 457
    Hi sle,

    You're right- I was working off $14m in the bank (as per their half yearly report)...

    Also from the half yearly which is very interesting:

    "PolyNovo is pursuing a number of potential product opportunities it has available to it under licensing arrangements with three of the world’s largest medical device companies, namely Medtronic Inc, Biomet and Smith & Nephew plc. PolyNovo is focused on developing a novel patented family of biodegradable polymers, NovoSorbTM, for use in medical devices. NovoSorbTM can be tailored to large world markets with potential applications in areas as diverse as orthopaedics, orthodontics, drug delivery, wound care, tissue engineering, nerve regeneration and cartilage repair."

    The contacts are already in place to distribute MBP's products globally!

    Cheers

    JB
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.